艾媒咨询 | 2024-2025年中国化妆品市场运行状况及发展趋势研究报告

在消费结构升级、审美观念和悦己意识增强等多种因素的推动下，国内化妆品消费持续增长。全球新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2024-2025年中国化妆品市场运行状况及发展趋势研究报告》数据显示，2023年中国化妆品行业市场规模约为5169.0亿元，同比增长6.4%，2025年有望增至5791.0亿元。近年来，国产化妆品品牌凭借高性价比与渠道精细化运营实现了迅速增长。在消费者对高端国际品牌整体祛魅的趋势下，国货品牌应将产品与营销的转型创新视为企业发展及再增长的关键，以满足市场的需求，提高企业竞争力。
Driven by many factors such as the upgrading of consumption structure, the enhancement of aesthetic concept and self-pleasing consciousness, domestic cosmetics consumption continues to grow. According to the latest "Research Report on the Operation Status and Development Trend of China's Cosmetics Market in 2024-2025" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's cosmetics industry in 2023 is about 516.09 billion yuan, an increase of 6.4%. It is expected to increase to 579.10 billion yuan by 2025. In recent years, domestic cosmetics brands have achieved rapid growth with high cost performance and refined channel operation. Under the trend of consumers' overall disenchantment of high-end international brands, domestic brands should regard the transformation and innovation of products and marketing as the key to the development and re-growth of enterprises, so as to meet the needs of the market and improve the competitiveness of enterprises.

艾媒咨询｜2022-2023年中国调味品行业商业洞察及发展潜力研究报告

数据显示，预计2022年中国调味料市场规模达到4466亿元，2025年市场规模达7881亿元。疫情使餐饮消费从外食转向家庭烹饪场景，提升了C端调味品需求，多家布局家庭端的调味品企业在疫情期间的收入保持了良好增长。

艾媒咨询｜2022年中国幽门螺旋杆菌检测市场专题调查报告

美国将幽门螺杆菌被列为明确致癌物后，幽门螺杆菌在中国受到了极大的关注。iiMedia Research（艾媒咨询）数据显示，2021年中国幽门螺杆菌检测市场规模73.1亿元，预计2022年将达到86.6亿元。艾媒咨询分析师认为，随着大众的健康意识逐渐加强，幽门螺杆菌自测产品将成为必需品，幽门螺杆菌检测市场发展空间广阔。而幽门螺杆菌自测产品的上市，有助于推动居家检测。(《艾媒咨询｜2022年中国幽门螺旋杆菌检测市场专题调查报告》完整高清PDF版共23页，可点击文章底部报告下载按钮进行报告下载)
After the United States Department of Health & Human Services listed Helicobacter pylori as a definitive carcinogen, Helicobacter pylori received great attention in China. According to data from iiMedia Research, the market size of Helicobacter pylori testing in China will be 7.31 billion yuan in 2021 and is expected to reach 8.66 billion yuan in 2022. With increasing health awareness, Helicobacter pylori self-test product is necessary for people. The market for Helicobacter pylori self-test product is vast. The launch of Helicobacter pylori self-test products helps to promote home testing.（“iiMedia Report ｜Investigation Report on The Market of Helicobacter Pylori Testing in China in 2022”full version has 23 pages, please click the Browse HD Report button on the right side of the article to browse the report）

艾媒咨询|2021年10-11月中国本地生活行业投融资数据分析简报

伴随消费升级，消费者需求逐渐多样化，本地生活服务面进一步扩大。如今，本地生活行业已逐步迈进万亿市场。近年来，在数字经济的加持下，本地生活行业进行了数字化升级，并发展成为最活跃的行业之一，得到了资本市场的大量关注。艾媒咨询通过艾媒数据中心(data.iimedia.cn)查询并发布《2021年10-11月中国本地生活行业投融资数据分析简报》，助力投资人与创业者用户即时了解市场趋势，获取关键投资决策所需的数据，把握投资逻辑和最新产业机会。
With the upgrading of consumption, consumer demand is gradually diversified, and the local life service area is further expanded. Today, the local living industry has gradually entered a trillion market. In recent years, with the support of the digital economy, the local living industry has been digitally upgraded and developed into one of the most active industries, which has attracted a lot of attention from the capital market.iiMedia Research inquires and publishes the analysis briefing on investment and financing data of local life industry in China from October to November 2021 through iimedia data center (data. iimedia.cn), which helps investors and entrepreneurs understand the market trend in real time, obtain the data required for key investment decisions, and grasp the investment logic and the latest industrial opportunities.

艾媒咨询|2021年9月中国医疗健康行业投融资数据分析报告

人口老龄化，人均GDP、人均收入的提升，同时也带来了人们健康需求的增长。近年来，医疗健康产业创新不断涌现，并发展成为最活跃的行业之一，相关细分赛道也维持着较高的增长，收获了资本市场的大量关注。
艾媒咨询通过艾媒数据中心(data.iimedia.cn)查询并发布《2021年9月中国医疗健康行业投融资数据分析简报》，助力投资人与创业者用户即时了解市场趋势，获取关键投资决策所需的数据，把握投资逻辑和最新产业机会。(《艾媒咨询|2021年9月中国医疗健康行业投融资数据分析报告》完整高清PDF版共21页，可点击文章底部报告下载按钮进行报告下载)
The aging of population and the increase of per capita GDP and per capita income have also brought about the growth of people's health demand. In recent years, the innovation of medical and health industry has been emerging and developed into one of the most active industries. The relevant segments have also maintained high growth and gained a lot of attention from the capital market.
Iimedia inquires and publishes the analysis briefing on investment and financing data of “China's medical and health industry in September 2021 through iimedia data center (data. Iimedia. cn), so as to help investors and entrepreneurs understand the market trend in real time, obtain the data required for key investment decisions, and grasp the investment logic and the latest industrial opportunities.(“iiMedia Report |Analysis report on investment and financing data of China's medical and health industry in September 2021”full version has 21 pages in total, please click the Browse HD Report button on the right side of the article to browse the report)

艾媒咨询|2021年9-10月中国化妆品行业运行数据监测双月报：“双十一” 战报

本报告涉及的案例/品牌/企业：C咖，悦瞳，林清轩

数据显示，今年年初社会消费品零售总额受去年低基数的影响，同比高增。自三月以来中国社会消费品零售总额与化妆品类商品零售值同比增长速度总体呈现下滑趋势。艾媒咨询分析师认为，受中国疫情零星出现以及宏观经济景气度等原因，居民总体消费意愿减弱，如将来疫情仍未解决，或一定程度影响化妆品消费的总体需求。不过，从数据来看，今年美妆护肤类产品线上复购需求多于线下体验需求，且对即时性要求不高，在整体电商经济增速下降的环境下，未来美妆护肤类产品线上销售增速仍能够保持高增长趋势。
Data show that at the beginning of this year, the total retail sales of social consumer goods increased year-on-year due to the impact of last year's low base. Since March, the year-on-year growth rate of China's total retail sales of social consumer goods and the retail value of cosmetics has generally shown a downward trend. iiMedia Research analysts believe that due to the sporadic occurrence of the epidemic in China and the macroeconomic boom, the overall consumption willingness of residents is weakened. If the epidemic has not been solved in the future, it may affect the overall demand for cosmetics consumption to a certain extent. However, from the data, this year, the demand for online re purchase of beauty and skin care products is more than the demand for offline experience, and the requirement for timeliness is not high. Under the environment of declining overall e-commerce economic growth, the growth rate of online sales of beauty and skin care products can still maintain a high growth trend in the future.

艾媒咨询|2021年中国宠物经济产业研究报告

本报告研究涉及企业/品牌/案例：朝云集团，汉欧生物科技，麦富迪

在当前的新消费模式下，宠物经济呈现新的特点。一是线上线下双发展，约九成消费者在线下进行宠物消费，同时也有超过八成消费者在线上进行宠物消费;二是国货品牌更受青睐，三是资本入驻，宠物品牌积极开拓竞争力，寻找可持续发展空间。这一时期如朝云集团、汉欧生物发展思路良好，脱颖而出。
Under the current new consumption model, the pet economy presents new characteristics. The first is the dual development of online and offline. About 90% of consumers consume pets offline, and more than 80% of consumers consume pets online; second, domestic brands are more popular; third, capital is settled, and pet brands are actively developing their competitiveness , Looking for sustainable development space. During this period, Zhaoyun Group and Hanou Biology had good development ideas and stood out.

艾媒咨询|2021年中国轻医美行业研究及产业链分析报告

本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物

数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization.

艾媒咨询|2021年3-4月中国化妆品行业运行数据监测双月报

本报告研究涉及企业/品牌/案例：花西子，资生堂，华熙生物

数据显示，中国化妆品及洗护用品进出口金额均呈现大幅度增长状态，并未受到2020年新冠疫情较大的负面影响。2021年1-4月，中国化妆品及洗护用品进口数量为14.6万吨，出口数量为29.2万吨；2021年1-4月，中国化妆品及洗护用品进口金额为515.8亿元，出口金额为84.4亿元。随着国内经济全面复苏，中国化妆品的出口数量有明显的增加趋势，照此趋势，预计2021年全年中国化妆品及洗护用品进出口金额或将有新的高峰。
Data show that the import and export volume of cosmetics and toiletries in China has increased significantly, and has not been seriously affected by COVID-19 in 2020. From January to April in 2021, China's imports of cosmetics and toiletries were 146000 tons and exports were 292000 tons; From January to April 2021, China's imports of cosmetics and toiletries amounted to 51.58 billion yuan, and its exports amounted to 8.44 billion yuan. With the comprehensive recovery of domestic economy, the export volume of China's cosmetics has an obvious increasing trend. According to this trend, it is expected that the import and export amount of China's cosmetics and toiletries will reach a new peak in 2021.

艾媒咨询|2021全球及中国大健康产业运行大数据及决策分析报告

本报告研究涉及企业/品牌/案例：阿里健康，联合丽格，恒瑞医药，白云山，平安好医生，111集团，新氧，药明巨诺，盘龙药业，先导药业，好大夫在线，优健康，春雨医生，丁香医生，微医

受到人口老龄化、居民患病比例增加等因素影响，国家医疗费用支出不断增加，属于刚性需求；同时，随着人们对健康标准的不断提高以及互联网医疗技术的发展，大健康产业会在相当长的时期内持续保持增长态势。数据显示，2020年中国的大健康产业营收规模超过7万亿元，预计2021年将达8万亿元，增幅达8.1%。其中，得益于大健康产业发展以及疫情期间医药需求增长，生物制药、医疗器械两大细分领域表现良好，成为2020年中国投资热度较高的新经济行业，投资项目金额分别为919亿元和273亿元。
Affected by the aging population and the increasing proportion of residents, the national medical expenditure is increasing, which belongs to the rigid demand; At the same time, with the continuous improvement of people's health standards and the development of internet medical technology, the big health industry will continue to grow for a long time. According to the data, the revenue of China's big health industry will exceed 7 trillion yuan in 2020, and it is expected to reach 8 trillion yuan in 2021, an increase of 8.1%. Among them, thanks to the development of big health industry and the growth of pharmaceutical demand during the epidemic period, biopharmaceuticals and medical devices have performed well, becoming China's new economy industry with high investment enthusiasm in 2020, with investment projects of 91.9 billion yuan and 27.3 billion yuan respectively.